Whitehall-Robins Chap Stick Labeling Exemption Request Denied
This article was originally published in The Tan Sheet
Executive Summary
FDA will not grant labeling exemptions based solely on financial considerations, the agency states in a Sept. 18 letter to Whitehall-Robins denying the company's request for an exemption from the OTC labeling final rule for three Chap Stick Flava-Craze skin protectant lip balm SKUs.
You may also be interested in...
AHP Dimetapp, Robitussin PPA Withdrawals Lead To $80 Mil. Charge In 2000
American Home Products recorded an $80 mil. charge in the fourth quarter due to its removal of eight Dimetapp products and one Robitussin item in response to data linking phenylpropanolamine with hemorrhagic stroke, the company said Jan. 25.
AHP Dimetapp, Robitussin PPA Withdrawals Lead To $80 Mil. Charge In 2000
American Home Products recorded an $80 mil. charge in the fourth quarter due to its removal of eight Dimetapp products and one Robitussin item in response to data linking phenylpropanolamine with hemorrhagic stroke, the company said Jan. 25.
AHP Dimetapp, Robitussin PPA Withdrawals Lead To $80 Mil. Charge In 2000
American Home Products recorded an $80 mil. charge in the fourth quarter due to its removal of eight Dimetapp products and one Robitussin item in response to data linking phenylpropanolamine with hemorrhagic stroke, the company said Jan. 25.